RxDoctor Payments Data

Theresa Mattingly, MD

Dermatology · Lees Summit, MONPI 1265849053

Payments from drug & device makers

$5,590in general payments, 2019–2025

Across 281 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$933
  • Dermavant Sciences, Inc.$401
  • Biofrontera Inc.$373
  • Johnson & Johnson$315
  • Pfizer$218
  • plus $2K from 29 others

What the payments were for

  • Speaking & faculty fees$2504%
  • Food & beverage$5,24094%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,590 in reported general payments places this provider in the 60th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri

Medicare billing

Part B allowed, 2024
$376,203
Medicare patients
1,059
Services billed
6,988

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa15$302,455
Dupixent PenDupilumab51$194,009
Enbrel SureclickEtanercept13$189,086
Cosentyx Sensoready (2 Pens)Secukinumab13$93,308
XolairOmalizumab24$66,611
Dupixent SyringeDupilumab14$52,389
Clobetasol Propionate167$7,979
Fluorouracil72$6,939
Triamcinolone Acetonide210$2,395
Metronidazole32$2,386
Ketoconazole143$1,708
Minoxidil115$1,685
Doxycycline Hyclate61$1,288
Betamethasone Dipropionate27$1,143
Clindamycin Phosphate23$991

Paid to pharmacies, not to this prescriber.

Other dermatology in Lees Summit

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →